ArticleBiomaterials research2025
Prominent Alveolar Bone Graft Substitute Derived from Silk Fibroin/Hyaluronic Acid/Demineralized Dentin Matrix Hybrid Hydrogel.
Article in Biomaterials research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Innovative Hydroxyapatite-Hydrogel Composites for Cartilage Regeneration.Gels (Basel, Switzerland) · 2026Review
- Demineralization of Camel Dentin for Dental Tissue Engineering.International dental journal · 2026Article
- Innovative 3D-bioprinted microfibers in calcium phosphate cement platform with Nell-1 to activate nerve-bone axis for synergistic bone, vasculature, and nanofibrous nerve regeneration.Smart molecules : open access · 2026Article
- Glycosaminoglycans in tissue regeneration: Insights into glycobiology and their biomedical application.Bioactive materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone graft substitutes are commonly used to repair large bone defect, and restoring the alveolar bone defects in height and width is a major challenge in restorative dentistry. In comparison with clinic bone graft substitutes such as bovine-derived powder and hydroxyapatite, demineralized dentin matrix (DDM) is a valuable alternative due to its compositional similarity to human-derived bone. However, a challenge remains in using DDM for bone rehabilitation, particularly in maintaining spatial morphology due to its granular form. This study developed an effective bone graft substitute using DDM particles in a fast-cured silk fibroin/hyaluronic acid methacrylate (SF/HAMA) hydrogel, which adheres well to the alveolar bone defect and rapidly gels under blue light. In vitro and in vivo experiments were performed to evaluate the biocompatibility of this hybrid hydrogel. The ability to repair bone defects was tested on cranial defects in rats and mandibular defects in beagles. Results showed that the in situ composites exhibited excellent mechanical strength and biocompatibility, with micro-computed tomography and histology confirming the best bone regeneration effect of the SF/HAMA/DDM-50 hybrid hydrogel. This composited bone graft substitute could provide a novel strategy for the clinical treatment of alveolar bone defects and is a promising candidate for bone tissue reconstruction and regeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.